Structure Therapeutics, Inc. (GPCR)
45.49
-1.53
(-3.25%)
USD |
NASDAQ |
Apr 24, 16:00
45.72
+0.23
(+0.51%)
Pre-Market: 20:00
Structure Therapeutics Shareholders Equity (Quarterly) : 1.516B for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly & Co. | 26.54B |
| Viking Therapeutics, Inc. | 639.06M |
| Novo Nordisk A/S | 30.51B |
| Revolution Medicines, Inc. | 1.631B |
| Kymera Therapeutics, Inc. | 1.580B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.584B |
| Total Liabilities (Quarterly) | 67.54M |
| Debt to Equity Ratio | 0.0043 |
| Current Ratio | 24.81 |
| Net Debt Paydown Yield | -0.01% |